Crescita Therpeutc (TSE:CTX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Crescita Therapeutics has announced an exclusive agreement to distribute the MicronJet 600, the world’s smallest intradermal delivery device, in Canada’s medical aesthetics market. The device promises precise, minimally invasive, and comfortable injections, an innovation welcomed by practitioners and patients. It is already CE marked and FDA cleared, with Crescita planning a Canadian launch in the first half of 2025, post Health Canada approval.
For further insights into TSE:CTX stock, check out TipRanks’ Stock Analysis page.
